Due to an increase in doses that the Department of Health will receive from the vaccine Johnson & Johnson, Puerto Rico will have 135,070 vaccines available against it Covid-19 for each of the next two weeks, an increase of just over 22,000 over the 113,000 allocated this week.
In this context, the designated secretary of the Department of Health, Carlos Mellado, He anticipated that he will soon announce another expansion of the population eligible to receive the vaccine. At the moment, the country is in the subphase 1-C, Missing to open only the subphase 2, Which includes the entire population aged 16 and over.
We recommend:
Johnson & Johnson’s allocation, which only requires one dose, will amount to 51,400 vaccines next week, after 20,300 were received this week.
Johnson & Johnson’s shipment will compensate for a reduction in the first doses of Pfizer, Of which 47,970 vaccines will be received, as opposed to the 58,500 that arrived for this week. In the case of the vaccine Modern, The island will receive 35,700 first doses, a slight increase from the 34,200 that arrived this week.
The press office of the Department of Health has also indicated that another 47,970 vaccines corresponding to the second dose of Pfizer will arrive in Puerto Rico, as well as 34,200 second doses of the Moderna brand.
The grand total of vaccines received, therefore, will amount to 217,240 vaccines in the coming week, a difference of 23,240 compared to 194,000 this week.
The figures do not include vaccines that the federal government allocates directly to large pharmacy chains or community pharmacies.
Loss of Johnson & Johnson vaccines
Mellado, however, clarified that, for the last week of April, there will be a reduction in the number of vaccines received, as a result of the production error in Johnson & Johnson vaccines, which caused the loss of about 15 million doses.
“We will have a drop in the vaccine Janssen (A subsidiary of Johnson & Johnson that manufactures the antidote), ”Mellado said, not estimating how much the decline would be in Puerto Rico.
Faced with concerns that may arise about the quality of Johnson & Johnson’s product, the Department of Health clarified that the doses arriving on the island correspond to vaccines produced in the Netherlands, not the Maryland state factory. where the manufacturing failure was detected.
On the expansion of vaccination, Mellado did not specify whether, in effect, the process would be completely opened up or some kind of subdivision would be implemented within the general population. the president Joe Biden has demanded that, by May 1, the entire adult population be able to get a turn to inoculate.
“It should be seen. I have to sit with (the staff of the Vaccination Program). My projection is to start with the vaccine to everyone (by May 1), “the official argued to questions from the press.
The digital board of Health has registered about 679,420 people who have received at least one dose of the vaccine, of which 381,452 have already completed the cycle. In Puerto Rico, 1,060,872 doses were administered among all available vaccines.